Table 3. Adverse events by major... | American Society of Hematology

Table 3.

Adverse events by major toxicities

Toxicity group	Adverse events	Grade								Total
Toxicity group	Adverse events	1		2		3		4		Total
Hematologic	Anemia	0	0%	0	0%	1	2.6%	0	0%	1	2.6%
	Neutropenia	0	0%	0	0%	1	2.6%	1	2.6%	2	5.3%
Cardiovascular	Heart failure	0	0%	1	2.6%	0	0%	0	0%	1	2.6%
Gastrointestinal/liver	Abdominal pain	0	0%	0	0%	1	2.6%	0	0%	1	2.6%
	Diarrhea	1	2.6%	0	0%	0	0%	0	0%	1	2.6%
	Dysphagia	0	0%	1	2.6%	0	0%	0	0%	1	2.6%
	Transaminitis	1	2.6%	0	0%	0	0%	0	0%	1	2.6%
General and infusion related	Fatigue	1	2.6%	0	0%	0	0%	0	0%	1	2.6%
	Urticaria	0	0%	1	2.6%	0	0%	0	0%	1	2.6%
	Edema in limbs	1	2.6%	0	0%	0	0%	0	0%	1	2.6%
Infection	Bacterial	0	0%	5	13.2%	7	18.4%	1	2.6%	13	34.2%
	Viral	1	2.6%	16	42.1%	6	15.8%	3	7.9%	26	68.4%
	Fungal	1	2.6%	2	5.3%	2	5.3%	3	7.9%	8	21.1%
	Unidentified	2	5.3%	5	13.2%	7	18.4%	0	0%	14	36.8%
Electrolyte abnormalities	Hypocalcemia	0	0%	0	0%	1	2.6%	0	0%	1	2.6%
Neurologic	Pre-syncope	0	0%	1	2.6%	0	0%	0	0%	1	2.6%

Toxicity group	Adverse events	Grade								Total
Toxicity group	Adverse events	1		2		3		4		Total
Hematologic	Anemia	0	0%	0	0%	1	2.6%	0	0%	1	2.6%
	Neutropenia	0	0%	0	0%	1	2.6%	1	2.6%	2	5.3%
Cardiovascular	Heart failure	0	0%	1	2.6%	0	0%	0	0%	1	2.6%
Gastrointestinal/liver	Abdominal pain	0	0%	0	0%	1	2.6%	0	0%	1	2.6%
	Diarrhea	1	2.6%	0	0%	0	0%	0	0%	1	2.6%
	Dysphagia	0	0%	1	2.6%	0	0%	0	0%	1	2.6%
	Transaminitis	1	2.6%	0	0%	0	0%	0	0%	1	2.6%
General and infusion related	Fatigue	1	2.6%	0	0%	0	0%	0	0%	1	2.6%
	Urticaria	0	0%	1	2.6%	0	0%	0	0%	1	2.6%
	Edema in limbs	1	2.6%	0	0%	0	0%	0	0%	1	2.6%
Infection	Bacterial	0	0%	5	13.2%	7	18.4%	1	2.6%	13	34.2%
	Viral	1	2.6%	16	42.1%	6	15.8%	3	7.9%	26	68.4%
	Fungal	1	2.6%	2	5.3%	2	5.3%	3	7.9%	8	21.1%
	Unidentified	2	5.3%	5	13.2%	7	18.4%	0	0%	14	36.8%
Electrolyte abnormalities	Hypocalcemia	0	0%	0	0%	1	2.6%	0	0%	1	2.6%
Neurologic	Pre-syncope	0	0%	1	2.6%	0	0%	0	0%	1	2.6%